The effect of ARB on the improvement of the PWV level is not superior to other types of antihypertensive agents , but ARB is superior to other types of antihypertensive agents for improving the AI level .
Overall , to improve of arterial stiffness , ARB maybe is superior to other antihypertensive agents
BACKGROUND This system review and meta- analysis was conducted to systematic ally review and analyze the clinical benefits of different antihypertensive agents in improving arterial stiffness in hypertensive patients .
Effects of Angiotensin II Type 1 Receptor Blocker on Blood Pressure Variability and Cardiovascular Remodeling in Hypertensive Patients on Chronic Peritoneal Dialysis
Aims : In this study , we examined whether addition of an angiotensin II type 1 receptor blocker ( ARB ) , c and esartan or valsartan , to conventional antihypertensive treatment could improve blood pressure ( BP ) variability in hypertensive patients on peritoneal dialysis . Methods : 45 hypertensive patients on chronic peritoneal dialysis therapy were r and omly assigned to the ARB treatment groups either by c and esartan ( n = 15 ) or valsartan ( n = 15 ) , or the control group ( n = 15 ) . At baseline and 6 months after the treatment , 24-hour ambulatory BP monitoring , echocardiography  , and measurement of brachial-ankle pulse wave velocity ( baPWV ) were performed . Results : After the 6 months of treatment , 24-hour ambulatory BP values were similarly decreased in both the control group and ARB groups . However , short-term BP variability assessed on the basis of the st and ard deviation of 24-hour ambulatory BP was significantly decreased in the ARB groups , but remained unchanged in the control group . Furthermore , parameters of cardiovascular remodeling assessed by natriuretic peptides , echocardiography , and baPWV were significantly improved in the ARB groups but not in the control group . Conclusion : ARB treatment and control antihypertensive treatment similarly controlled 24-hour ambulatory BP values in hypertensive patients on peritoneal dialysis . However , ARB treatment is beneficial for the suppression of pathological cardiovascular remodeling with a decrease in BP variability
The effect of ARB on the improvement of the PWV level is not superior to other types of antihypertensive agents , but ARB is superior to other types of antihypertensive agents for improving the AI level .
Overall , to improve of arterial stiffness , ARB maybe is superior to other antihypertensive agents
BACKGROUND This system review and meta- analysis was conducted to systematic ally review and analyze the clinical benefits of different antihypertensive agents in improving arterial stiffness in hypertensive patients .